This inventor holds 1 USPTO granted patent. Top assignee: Hamari Chemicals, Ltd.. Active years: 2002.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002
Title: Masakatsu Nozaki: Innovator in Diabetes Treatment
Introduction
Masakatsu Nozaki is a prominent inventor based in Gifu, Japan. He has made significant contributions to the field of diabetes treatment through his innovative research and development. His work focuses on the use of zinc tranexamate, a compound that has shown promise in managing diabetes effectively.
Latest Patents
Masakatsu Nozaki holds a patent for the use of zinc tranexamate in the treatment of diabetes. This patent discloses a new application of the zinc tranexamate compound, which aids in slowing down the absorption of glucose from the digestive tract by inhibiting α-glucosidase in vivo. The compound has also proven effective in treating insulin-resistant type II diabetes. He has 1 patent to his name.
Career Highlights
Nozaki is associated with Hamari Chemicals, Ltd., where he continues to advance his research in diabetes treatment. His work has garnered attention for its potential to improve the quality of life for individuals suffering from diabetes.
Collaborations
Masakatsu Nozaki has collaborated with notable colleagues, including Hajime Fujimura and Shun-ichi Tanaka. Their combined expertise has contributed to the development of innovative solutions in the field of diabetes management.
Conclusion
Masakatsu Nozaki's contributions to diabetes treatment through his patent on zinc tranexamate highlight his role as an influential inventor. His ongoing work at Hamari Chemicals, Ltd. continues to pave the way for advancements in medical treatments for diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile